risedronic acid has been researched along with Arthritis, Degenerative in 9 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoarthritis was surgically induced on one knee of 32 New Zealand White rabbits using the contralateral as healthy controls." | 5.40 | Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. ( Caeiro, JR; González-Cantalapiedra, A; Guede, D; López-Peña, M; Muñoz, F; Permuy, M, 2014) |
| "Osteoarthritis is thought to be the most prevalent chronic and disabling joint disease in animals and humans and its treatment is a major orthopaedic challenge because there is no ideal drug treatment to preserve joint structure and function, as well as to ameliorate the symptomatology of the disease." | 1.42 | Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits. ( Caeiro, JR; González-Cantalapiedra, A; Guede, D; López-Peña, M; Muñoz, F; Permuy, M, 2015) |
| "Osteoarthritis was surgically induced on one knee of 32 New Zealand White rabbits using the contralateral as healthy controls." | 1.40 | Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. ( Caeiro, JR; González-Cantalapiedra, A; Guede, D; López-Peña, M; Muñoz, F; Permuy, M, 2014) |
| " In two groups, anterior cruciate ligament transection was performed and half were left untreated, and the other half dosed with risedronate (0." | 1.35 | Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy. ( Boyd, SK; Doschak, MR; MacNeil, JA; Zernicke, RF, 2008) |
| " We surgically transected the anterior cruciate ligament (ACLX) in two groups of rabbits; the first group was dosed with BP (risedronate, 0." | 1.32 | Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. ( Bray, RC; Doschak, MR; Hanley, DA; Wohl, GR; Zernicke, RF, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomsen, JS | 1 |
| Straarup, TS | 1 |
| Danielsen, CC | 1 |
| Oxlund, H | 1 |
| Brüel, A | 1 |
| Permuy, M | 2 |
| Guede, D | 2 |
| López-Peña, M | 2 |
| Muñoz, F | 2 |
| González-Cantalapiedra, A | 2 |
| Caeiro, JR | 2 |
| Bruyère, O | 1 |
| Burlet, N | 1 |
| Delmas, PD | 1 |
| Rizzoli, R | 1 |
| Cooper, C | 1 |
| Reginster, JY | 1 |
| Yemisci, OU | 1 |
| Yalbuzdag, SA | 1 |
| Karatas, M | 1 |
| Doschak, MR | 2 |
| Wohl, GR | 1 |
| Hanley, DA | 1 |
| Bray, RC | 1 |
| Zernicke, RF | 2 |
| Felson, DT | 1 |
| Kim, YJ | 1 |
| MacNeil, JA | 1 |
| Boyd, SK | 1 |
| Kawasaki, T | 1 |
| Kurosawa, H | 1 |
| Ikeda, H | 1 |
| Kim, SG | 1 |
| Osawa, A | 1 |
| Takazawa, Y | 1 |
| Kubota, M | 1 |
| Ishijima, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis[NCT04303026] | Phase 3 | 70 participants (Anticipated) | Interventional | 2020-03-02 | Recruiting | ||
| Pilot, Open Non-controled Trial to Assess the Feasibility of Implementing Objective Parameters as Primary Endpoints in a Clinical Trial With Patients Affected by Knee Osteoarthritis[NCT03421054] | 8 participants (Actual) | Interventional | 2018-03-19 | Completed | |||
| Double Blind, Placebo Controlled Trial to Evaluate the Effects of a Nutraceutical Containing High-Molecular-Weight Hyaluronic Acid (HA) and Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) in Patients Affected by Knee Osteoarthritis[NCT03612986] | 72 participants (Actual) | Interventional | 2018-08-22 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for risedronic acid and Arthritis, Degenerative
| Article | Year |
|---|---|
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Topics: Anthraquinones; Antirheumatic Agents; Calcitonin; Chondroitin Sulfates; Clinical Trials as Topic; Et | 2008 |
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Topics: Anthraquinones; Antirheumatic Agents; Calcitonin; Chondroitin Sulfates; Clinical Trials as Topic; Et | 2008 |
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Topics: Anthraquinones; Antirheumatic Agents; Calcitonin; Chondroitin Sulfates; Clinical Trials as Topic; Et | 2008 |
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Topics: Anthraquinones; Antirheumatic Agents; Calcitonin; Chondroitin Sulfates; Clinical Trials as Topic; Et | 2008 |
The futility of current approaches to chondroprotection.
Topics: Anti-Bacterial Agents; Bone Density Conservation Agents; Cartilage, Articular; Chondrocytes; Doxycyc | 2007 |
1 trial available for risedronic acid and Arthritis, Degenerative
| Article | Year |
|---|---|
Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; | 2008 |
6 other studies available for risedronic acid and Arthritis, Degenerative
| Article | Year |
|---|---|
No effect of risedronate on articular cartilage damage in the Dunkin Hartley guinea pig model of osteoarthritis.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Calcification, Physiologic; Cartilage, A | 2013 |
Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis.
Topics: Animals; Bone Density Conservation Agents; Etidronic Acid; Female; Glucosamine; Humans; Osteoarthrit | 2014 |
Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Arthrography; Bone Density Conservation Agents; C | 2015 |
Risedronate-induced arthritis.
Topics: Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Middle Aged; Osteoarthritis; Osteo | 2010 |
Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee.
Topics: Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Bone Density; Etidronic Acid; Osteoart | 2004 |
Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Computer Simulation; Disease Models, Ani | 2008 |